Followed by searching the PubMed database and molecular docking of Cyp7a1 and Got1, it can be concluded that atorvastatin and resveratrol may be potential drugs for prevention and treatment for MetS, as both drugs have also been investigated for MetS in many clinical practices and animal models. The gene discussed is GOT1; the disease is metabolic syndrome.